What are you for
I'm Orris, a knowledgeable AI assistant built to help you across a wide range of topics. Here's what I can do:
General Knowledge
- Answer questions on science, history, math, technology, culture, and more
- Explain complex concepts in plain language
Medical & Clinical
- Look up drugs, diagnoses, symptoms, treatments, anatomy, physiology, and pharmacology from authoritative medical textbooks
- Surface relevant peer-reviewed research from PubMed
Research & Evidence
- Search the web for current information and news
- Find and summarize recent studies and clinical guidelines
Document & File Work
- Create and edit Word documents (.docx), PowerPoint presentations (.pptx), Excel spreadsheets (.xlsx), and PDFs
- Read and extract content from uploaded files
Specialized Knowledge
- Indian taxation (direct taxes, income tax, transfer pricing)
- GST and indirect taxes, CA/ACCA exam prep
- Orthopaedic/surgical content from clinical guidelines and video transcripts
Coding & Computation
- Write and run code in a sandbox environment
- Analyze data, generate charts, perform calculations
Just ask me anything - I'll give you a direct, accurate answer and pull in the best sources available.
Can you make sma into cheap treatment plan
Asking for Preferences
Spinal mascular antropy
Asking for Preferences
Reading File
Finding Sources
Searching PubMed
"spinal muscular atrophy" AND "risdiplam" AND treatment
Searching the Web
SMA Type 2 treatment plan affordable alternatives to Spinraza Zolgensma risdiplam 2025
Reading File
Searching the Web
risdiplam Evrysdi patient assistance program free or low cost 2025 access developing countries
Reading File
Searching the Web
SMA Type 2 supportive care physiotherapy nutrition management low resource setting guidelines 2024 2025
Here is a practical, lower-cost treatment plan for SMA Type 2 (childhood-onset, intermediate form - children who can sit but cannot walk).
SMA Type 2 - Affordable Treatment Plan
Important disclaimer: This is educational information only. SMA management must be led by a neurologist and a multidisciplinary team. This plan focuses on what is achievable with limited budgets.
Understanding SMA Type 2
SMA Type 2 is caused by deletion of the SMN1 gene on chromosome 5q, leading to progressive loss of spinal motor neurons. Children typically sit independently but never walk. The key goals are: slow progression, prevent complications, and preserve function. - Bradley and Daroff's Neurology in Clinical Practice
Tier 1 - FREE / Very Low Cost (Supportive Care)
These interventions form the backbone of SMA management regardless of budget. Most are free or very low cost.
1. Physiotherapy (Physical Therapy)
- Passive range-of-motion exercises daily - prevents contractures in joints
- Hydrotherapy/pool therapy - buoyancy reduces load on weak muscles, improves movement
- Positioning - proper seating posture to prevent spinal deformity
- Breathing exercises - diaphragmatic and "air stacking" techniques to maintain lung capacity
- Many hospitals and charity clinics offer this free or subsidized
2. Respiratory Support
- SMA Type 2 children develop progressive respiratory weakness
- Non-Invasive Ventilation (NIV/BiPAP) during sleep - significantly extends life and improves quality
- BiPAP machines can often be obtained through insurance, government programs, or donations
- Cough assist device (manual or mechanical) - clears secretions and prevents pneumonia
- Pulse oximeter (~$15-30) for home monitoring of oxygen saturation
3. Nutrition Support
- Malnutrition and aspiration are major risks
- Nutritional assessment at every visit - monitor weight and growth curves
- High-calorie, nutrient-dense diet adapted for swallowing difficulties
- If swallowing is unsafe: nasogastric tube (NG tube) feeding is low-cost
- If long-term needed: gastrostomy (PEG tube) - one-time surgical cost, then low-cost ongoing feeding
- Work with a dietitian if possible
4. Orthopedic Support
- Custom wheelchair/adapted seating - many countries have government or charity programs
- Spinal bracing/orthoses - for scoliosis prevention (common in SMA Type 2, starts ~70% of patients)
- Ankle-foot orthoses (AFOs) - support positioning
- Surgical scoliosis correction (spinal fusion) may be needed later - costly but often done through government/NGO hospitals
5. Psychosocial Support
- Family counseling and parent training - often free through patient advocacy groups
- Contact CureSMA (curesma.org) or TREAT-NMD (treat-nmd.org) for free resources and care guides in multiple languages
Tier 2 - Most Affordable Disease-Modifying Drug
Risdiplam (Evrysdi) - ORAL, once daily
This is the most practical option for low-income settings because:
- It is taken by mouth (oral liquid) - no hospital visit or spinal injection needed
- No anesthesia required (unlike Spinraza/nusinersen which requires intrathecal injection)
- Works by increasing functional SMN protein from the SMN2 gene
Cost reduction pathways:
| Pathway | Details |
|---|---|
| Genentech Patient Foundation (US) | FREE for uninsured patients with income under $150,000/year. Call 1-888-941-3331 |
| Genentech co-pay program | Reduces out-of-pocket cost for insured US patients |
| Evrysdi Start Program | Free 30-day starter supply while insurance processes |
| Government reimbursement | Covered publicly in Canada, UK (NHS), Germany, Australia, and many EU countries |
| China access | Risdiplam available at significantly lower prices in China; some medical tourism |
| Clinical trials | Free drug through enrollment - check ClinicalTrials.gov |
| Roche/Genentech access programs | Roche runs country-specific access programs in low/middle-income countries - contact them directly |
Tier 3 - Higher Cost Options (for reference)
| Drug | Route | Cost (US list price) | Notes |
|---|---|---|---|
| Nusinersen (Spinraza) | Spinal injection every 4 months | ~$125,000/year | Requires hospital, anesthesia; lower-cost in some countries |
| Onasemnogene abeparvovec (Zolgensma) | IV infusion, once | ~$2.1 million | Approved only for age <2 years; NOT for SMA Type 2 in older children |
For SMA Type 2 in older children, Zolgensma is not indicated. Risdiplam or nusinersen are the options.
Multidisciplinary Team - Who You Need
A team approach, per International Standards of Care for SMA, is essential even with limited budgets:
- Pediatric neurologist (diagnosis, drug therapy)
- Pulmonologist/respiratory therapist (breathing support)
- Physiotherapist (movement, contracture prevention)
- Dietitian/nutritionist (feeding, growth)
- Orthopedic surgeon (scoliosis monitoring)
- Social worker (financial assistance, access programs)
Free Resources to Access Now
- CureSMA - patient advocacy, financial assistance guidance
- TREAT-NMD - international care standards, free guides
- Together in SMA - managing SMA resources
- Genentech Patient Foundation: 1-888-941-3331 (free Evrysdi for eligible patients)
Bottom Line
If disease-modifying therapy is the goal, risdiplam (Evrysdi) is the most accessible option - oral, once-daily, and available at no cost through the Genentech Patient Foundation for eligible uninsured/low-income patients in the US. In other countries, check national reimbursement programs or contact Roche directly. Regardless of drug access, the supportive care pillars (respiratory support, physiotherapy, nutrition, orthopedic care) are the most affordable and have the biggest impact on day-to-day quality of life and survival.
This is a shared conversation. Sign in to Orris to start your own chat.